Morton Grove Pharmaceuticals, Inc. v. National Pediculosis Ass'n

485 F. Supp. 2d 944, 2007 U.S. Dist. LEXIS 32618, 2007 WL 1302971
CourtDistrict Court, N.D. Illinois
DecidedMay 3, 2007
Docket06 C 3815
StatusPublished
Cited by2 cases

This text of 485 F. Supp. 2d 944 (Morton Grove Pharmaceuticals, Inc. v. National Pediculosis Ass'n) is published on Counsel Stack Legal Research, covering District Court, N.D. Illinois primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Morton Grove Pharmaceuticals, Inc. v. National Pediculosis Ass'n, 485 F. Supp. 2d 944, 2007 U.S. Dist. LEXIS 32618, 2007 WL 1302971 (N.D. Ill. 2007).

Opinion

MEMORANDUM OPINION AND ORDER

BUCKLO, District Judge.

Defendants Ecology Center, Inc. (“the Center”), John Fliegel, MD (“Fliegel”), and William B. Weil, MD (“Weil”) have brought a motion to dismiss counts II, III and TV of the complaint brought by plaintiff Morton Grove Pharmaceuticals, Inc., (“MGP”) for lack of personal jurisdiction under Fed. R. Civ. P. 12(b)(2), improper venue under Fed. R. Civ. P. 12(b)(3), or, in the alternative, to transfer the case to the Eastern District of Michigan, and for failure to state a claim under Fed. R. Civ. P. 12(b)(6). For the following reasons, the motion to dismiss for lack of personal jurisdiction is granted.

I.

MGP, a Delaware corporation, is a pharmaceutical company with its principal place of business in Morton Grove, Illinois. MGP manufactures Lindane Lotion and Lindane Shampoo (“collectively Lindane”), which are FDA-approved medications for the treatment of lice and scabies. These products are named after their active ingredient — lindane. Presently, MGP is the only United States manufacturer and distributor of Lindane.

The Center is a non-profit environmental group in Michigan. The Center’s sole place of business is Ann Arbor, Michigan and has never maintained offices, registered agents or employees in Illinois. Fliegel and Weil are physicians licensed to practice in the field of pediatric medicine in Michigan. Neither individual is licensed or alleged to have practiced medicine in Illinois. Both individuals reside in Michigan, where they have worked with the Center, and have never resided in Illinois.

MGP has filed claims for defamation (Count II), trade disparagement (Count III), and violations of the Illinois Deceptive Trade Practices Act, 815 ILCS 510/2 (Count III) against all defendants. The complaint specifically alleges that the Center, Fliegel, and Weil engaged in a false, misleading and defamatory attack campaign on MGP and its product, Lindane. As a result, MGP is alleged to have suffered a decline in the sale of Lindane and reputational injury. With regard to jurisdiction, the complaint alleges the Center “actively solicits donors by mail and distributes ‘fact sheets’ and ‘newsletters’ ... in Illinois;” “has raised money from eleven Illinois residents since December 2003;” “and has spent $2,900 in business and trav *947 el expenses in Illinois since February 2004.” (Compl. at ¶ 11.)

II.

On a motion to dismiss for lack of personal jurisdiction or improper venue, I read the complaint liberally and draw all reasonable inferences in favor of the plaintiff. Sapperstein v. Hager, 188 F.3d 852, 855 (7th Cir.1999). Where conflicting evidence is presented, I resolve factual disputes in the plaintiffs favor. RAR, Inc. v. Turner Diesel, Ltd., 107 F.3d 1272, 1275 (7th Cir.1997); Rotee Indus., Inc., v. Aecon Group, Inc., 436 F.Supp.2d 931, 933 (N.D.Ill.2006). The plaintiff has the burden to demonstrate that venue is proper and that this court has personal jurisdiction over the defendant. RAR, 107 F.3d at 1276; Cent. States, Southeast and Southwest Areas Pension Fund v. Phencorp Reinsurance Co., 440 F.3d 870, 875 (7th Cir.2006); Rotec Indus., 436 F.Supp.2d at 933.

A federal court exercising diversity jurisdiction has personal jurisdiction over the defendant if the state in which it sits would have such jurisdiction. RAR, 107 F.3d at 1275 (quoting Klump v. Duffus, 71 F.3d 1368, 1371 (7th Cir.1995)). This court’s exercise of personal jurisdiction must comport with Illinois statutory and constitutional law, and federal constitutional law. See id. at 1276. The Illinois long-arm statute provides that an Illinois court may exercise personal jurisdiction “on any ... basis now or hereafter permitted by the Illinois Constitution and the Constitution of the United States.” 735 ILCS 5/2-209(c). Therefore, I need only consider whether exercise of personal jurisdiction over defendants would be proper under Illinois and federal conceptions of due process.

Under the Due Process Clause of the Illinois Constitution, a court may exercise jurisdiction “when it is fair, just, and reasonable to require a nonresident defendant to defend an action in Illinois, considering the quality and nature of the defendant’s acts which occur in Illinois or which affect interests located in Illinois.” Rollins v. Ellwood, 141 Ill.2d 244, 275, 152 Ill.Dec. 384, 398, 565 N.E.2d 1302, 1316 (1990) (citation omitted). Although the Illinois Supreme Court contended in Rollins that the due process requirements under the Illinois constitution are distinct from the requirements of federal due process, see id., the Seventh Circuit has since affirmed that it is only in the rare, and perhaps hypothetical, case that the federal due process analysis might actually differ from the Illinois due process analysis. See Hyatt Int’l Corp. v. Coco, 302 F.3d 707, 715 (7th Cir.2002) (“[W]e note that in no case post -Rollins has an Illinois court found federal due process to allow the exercise of jurisdiction in a case where Illinois limits prohibited it.”).

Under the Due Process Clause of the Fourteenth Amendment, a defendant must have “certain minimum contacts with [the state] such that the maintenance of the suit does not offend ‘traditional notions of fair play and substantial justice.’ ” Hyatt Int’l, 302 F.3d at 716; Int’l Shoe Co. v. Washington, 326 U.S. 310, 316, 66 S.Ct. 154, 90 L.Ed. 95 (1945) (quoting Milliken v. Meyer, 311 U.S. 457, 463, 61 S.Ct. 339, 85 L.Ed. 278 (1940)). Here, MGP argues that this court may exercise both general and specific jurisdiction over the Center and only specific jurisdiction over Fliegel and Weil. Specific jurisdiction is jurisdiction that arises out of or relates to the defendant’s contacts with the forum. RAR, 107 F.3d at 1277 (citing Helicopteros Nacionales de Colombia, S.A. v. Hall, 466 U.S. 408, 414 n. 8, 104 S.Ct.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Jenkins ex rel. Miller-Jenkins v. Miller
983 F. Supp. 2d 423 (D. Vermont, 2013)

Cite This Page — Counsel Stack

Bluebook (online)
485 F. Supp. 2d 944, 2007 U.S. Dist. LEXIS 32618, 2007 WL 1302971, Counsel Stack Legal Research, https://law.counselstack.com/opinion/morton-grove-pharmaceuticals-inc-v-national-pediculosis-assn-ilnd-2007.